project id: TCGA-CESC; case submitter id: TCGA-VS-A9V4; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.38; rna integrity number: 7.1; age at index: 63; days to birth: -23334; days to death: 132; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1950; year of death: 2013; age at diagnosis: 23334; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic t: T4; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IVA; icd 10 code: C53.9; last known disease status: not reported; morphology: 8482/3; primary diagnosis: Mucinous adenocarcinoma, endocervical type; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: Not Reported; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 216; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-VS-A9V4-01A-12; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 1.0; percent necrosis: 20.0; percent neutrophil infiltration: 5.0; percent normal cells: 40.0; percent stromal cells: 0.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0;